Autonomous Surgical Robotics Market - A Global and Regional Analysis: Focus on Product Type, Application, End User, and Country - Analysis and Forecast, 2023-2033

Autonomous Surgical Robotics Market - A Global and Regional Analysis: Focus on Product Type, Application, End User, and Country - Analysis and Forecast, 2023-2033

Global Autonomous Surgical Robotics Market: An Overview

The global autonomous surgical robotics market was valued at $1.81 billion in 2022 and is anticipated to reach $11.07 billion by 2033, witnessing a CAGR of 17.45% during the forecast period 2023-2033. This growth can be attributed to the factors that include the enhanced surgical capabilities offered by autonomous robotic-assisted surgeries, an upsurge in minimally invasive surgical procedures, technological advancements in autonomous surgical robotics, and supportive regulatory approvals for autonomous surgical robotic systems, driving competitiveness in the market.

Market Lifecycle Stage

The market lifecycle stage of the autonomous surgical robotics market can be described as being in the early growth or introduction phase. This market segment is characterized by the emergence of innovative technologies and products that have the potential to transform the field of surgery. Autonomous surgical robots are still relatively new and are gaining attention due to their ability to improve surgical precision, reduce human error, and enhance patient outcomes. While there is growing interest and investment in this technology, the market is not yet fully mature, and there is ample room for expansion and development. As more research and development efforts pour in and as regulatory approvals are obtained, the market is expected to move into the growth phase, attracting a wider customer base and achieving more widespread adoption within the medical industry.

Industry Impact

The global autonomous surgical robotics market is having a profound impact on the healthcare industry and related sectors. Autonomous surgical robots have significantly enhanced surgical precision and reduced the likelihood of human error. This has led to improved surgical outcomes, reduced OT complications, and has led to shorter recovery times for patients. Technology has positively impacted the overall quality of healthcare services. The market for autonomous surgical robotics has driven advancements in minimally invasive surgery as well. These robots are particularly well-suited for such procedures, enabling smaller incisions, thereby leading to quick patient recovery and less trauma. This trend toward minimally invasive surgery has transformed the way many surgical procedures are performed, resulting in a more patient-friendly approach.

However, the shortage of skilled surgeons in many parts of the world is a growing concern. Autonomous surgical robots provide a viable solution by assisting surgeons, extending their capabilities, and potentially enabling remote surgery. This addresses the challenge of uneven access to surgical expertise and helps fill the gaps in underserved regions.

The global autonomous surgical robotics market is anticipated to grow at a robust pace due to the lucrative opportunities that lie within its domain, which include a massive scope for phenomenal profits through venturous investments, integrative industry-academia collaboration, the rise of advanced robotic technology, and an increase in the adoption of novel surgical applications. Some of the key trends that the market is moving toward include the rising technological innovations, such as next-generation robotic systems in the market.

Market Segmentation:

Segmentation 1: by Product Type

Robotic Systems
Consumables
Services

Robotic Systems to Dominate the Global Autonomous Surgical Robotics Market (by Product Type)

Based on product type, the robotics systems segment dominated the global autonomous surgical robotics market in FY2022. These advanced systems are gaining prominence due to their pivotal role in enhancing surgical procedures. With the ability to provide surgeons with precise control and dexterity, robotics systems have become a preferred choice in the autonomous surgical robotics market. Their capacity to minimize human error and improve patient outcomes makes them a vital component in the field of minimally invasive surgery. As the demand for more efficient and accurate surgical solutions continues to grow, robotics systems are expected to maintain their dominance, driving the market's evolution and expansion in the foreseeable future.

Segmentation 2: by Application

Urology Surgery
Orthopedic Surgery
Cardiology Surgery
Head and Neck (including Neurology) Surgery
Other Surgeries

Orthopedic Surgery to Dominate the Global Autonomous Surgical Robotics Market (by Application)

Based on application, orthopedic surgery dominated the global autonomous surgical robotics market in FY2022. This surgical field has emerged as a frontrunner in harnessing the benefits of autonomous surgical robotics. The precision, accuracy, and consistent performance of robotic systems have proven to be especially valuable in orthopedic procedures such as joint replacements and spine surgery. Surgeons are increasingly relying on these technologies to improve patient outcomes and reduce the invasiveness of surgeries. As the aging population grows and the demand for orthopedic interventions rises, the dominance of autonomous surgical robotics in orthopedic surgery is expected to persist and contribute significantly to the overall growth of the market.

Segmentation 3: by End User

Hospitals
Ambulatory Surgery Centers (ASCs)
Others

Hospitals to Dominate the Global Autonomous Surgical Robotics Market (by End User)

Based on end user, the hospitals segment dominated the global autonomous surgical robotics market in FY2022. These sophisticated surgical robotic systems are finding their primary home within hospital settings. Hospitals are at the forefront of adopting this technology due to its potential to improve patient care and surgical outcomes. The controlled environment, well-trained medical staff, and infrastructure in hospitals make them ideal places for the integration of autonomous surgical robotics. As the demand for advanced surgical techniques continues to rise, hospitals are expected to maintain their dominant position as key users of autonomous surgical robotics, ultimately driving the market's growth and evolution.

Segmentation 4: by Region

North America
Europe
Asia-Pacific
Latin America
Rest-of-the-World

Regions such as North America and Europe have technologically advanced healthcare systems and allocate considerable budgets to the healthcare segment, due to which these regions hold the maximum share in the global autonomous surgical robotics market. Regions such as Asia-Pacific, Latin America, and Rest-of-the-World are anticipated to register significant growth during the forecast period 2023-2033 owing to factors such as rising preference for minimally invasive surgeries, rising geriatric population, and increasing demand to streamline surgical workflows.

Moreover, Asia-Pacific is expected to register the highest CAGR of 18.87% during the forecast period 2023-2033. The Asia-Pacific region is an emerging market due to the rise in per capita income and rapid advancements in autonomous robotic surgical platforms. The Asia-Pacific region includes countries such as Japan, China, and India. Among these countries, China acquired the dominant market share, followed by Japan and India. Several companies have their presence in Asia-Pacific, such as Stryker Corporation, Zimmer Biomet Holdings, Inc., and Medtronic plc. The growth of the Asia-Pacific autonomous surgical robotics market is expected to be strongly driven by the increase in disposable income per household.

Recent Developments in the Global Autonomous Surgical Robotics Market

In September 2023, PROCEPT BioRobotics Corporation received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA). This approval would enable the company to investigate the safety and effectiveness of Aquablation therapy for the treatment of prostate cancer.
In May 2023, Robocath, Inc. launched its latest robotic platform, the R-One+, which could perform coronary angioplasties.
In October 2022, XACT Robotics Ltd. announced that its ACE Xtend Remote Control Unit received the U.S. Food and Drug Administration (FDA) clearance, allowing users to robotically insert and steer the XACT ACE Robotic System remotely from the control room.
In August 2022, THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, announced its entry into a development and distribution agreement with Curexo, Inc., a medical robotics specialist company based in South Korea. THINK and Curexo have a strong working relationship based on historical development collaboration, and Curexo distributes THINK's TSolution One platform in Korea and Vietnam.
In May 2022, XACT Robotics received FDA clearance that would expand support for ablation procedures.
In January 2022, Zimmer Biomet Holdings, Inc. partnered with American Hospital Dubai to provide advanced robotic-assisted training for orthopedic surgeons from the U.A.E. and the region.

Demand – Drivers, Restraints, and Opportunities

Market Demand Drivers:

Enhanced Surgical Capabilities Offered by Autonomous Robotic-Assisted Surgeries: Enhanced surgical capabilities are a driving force behind the autonomous surgical robotics market. These capabilities empower robotic systems to perform a wider range of surgical procedures, both complex and delicate, which makes them increasingly valuable in the medical field. One of the primary ways that enhanced surgical capabilities drive the market is by enabling a more extensive range of surgical procedures. Furthermore, there is an increased adoption of robotic-assisted surgeries owing to the several advantages over conventional as well as laparoscopic surgeries.

Market Restraints:

High Cost of Investment in Autonomous Robotic Surgical Systems: One of the major challenges in the autonomous surgical robotics market is the high capital cost of robotic systems, their associated instruments, and maintenance services. Currently, autonomous surgical robotics systems have a very high initial cost, requiring an arrangement for considerable capital investment from independent private surgeons and hospitals. All autonomous surgical robotic system manufacturers face several cost-associated challenges in convincing end users to purchase a robotic system.

Market Opportunities:

Preference of Telerobotic-Based Surgeries to Overcome Lack of Skilled Professional Surgeons: The preference for Telerobotic-based surgeries is emerging as a powerful opportunity for the autonomous surgical robotics market, particularly in overcoming the challenge of a shortage of skilled professional surgeons. The preference for telerobotic-based surgeries is fundamentally rooted in the shortage of skilled professional surgeons in many parts of the world. As populations grow and age, the demand for surgical interventions increases, and the supply of experienced surgeons often falls short.

How can this report add value to an organization?

Workflow/Innovation Strategy:The autonomous surgical robotics market (by application) has been segmented into different types of surgeries performed using autonomous surgical robots. Moreover, the study provides the procedure volume as well for these surgeries to provide a detailed understanding of how the different surgeries are expected to grow.

Growth/Marketing Strategy:To foster growth and success in the autonomous surgical robotics market, a comprehensive marketing strategy is crucial. Establishing strategic partnerships with device manufacturers and obtaining regulatory approvals swiftly will be key for market penetration. Customer-focused marketing that highlights the enhanced patient outcomes and cost-effectiveness of autonomous surgical robotics is essential.

Competitive Strategy:Key players in the global autonomous surgical robotics market have been analyzed and profiled in the study, including manufacturers involved in new product launches, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the global autonomous surgical robotics market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation
The base year considered for the calculation of the market size is 2022. The historical year analysis has been done from FY2020 to FY2021, and the market size has been calculated for FY2022 and projected for the period 2023-2033.
The geographical distribution of the market revenue is estimated to be the same as the company’s net revenue distribution. All the numbers are adjusted off to two digits after decimal for report presentation reasons. However, the real figures have been utilized for compound annual growth rate (CAGR) estimation. CAGR is calculated from 2023 to 2033.
The market has been mapped based on different types of products available in the market and based on several indications. All the key manufacturing companies that have a significant number of offerings to the autonomous surgical robotics market have been considered and profiled in the report.
In the study, the primary respondent’s verification has been considered to finalize the estimated market for the autonomous surgical robotics market.
The latest annual reports of each market player have been taken into consideration for market revenue calculation.
Market strategies and developments of key players have been considered for the calculation of sub-segment split.
The base currency considered for the market analysis is US$. Currencies other than the US$ have been converted to the US$ for all statistical calculations, considering the average conversion rate for that particular year. The currency conversion rate has been taken from the historical exchange rate of the Oanda website or from the annual reports of the respective company, if stated.

Primary Research

The key data points taken from the primary sources include:

Validation and triangulation of all the numbers and graphs
Validation of the report’s segmentation and key qualitative findings
Understanding of the numbers of the various markets for market type
Percentage split of individual markets for regional analysis

Secondary Research

Open Sources

National Center for Biotechnology Information (NCBI), PubMed, Science Direct, World Bank Group, Organisation for Economic Co-operation and Development (OECD), Centers for Disease Control and Prevention (CDC), Global Burden Disease (GBD), and World Health Organization (WHO)
Annual reports, SEC filings, and investor presentations of the leading market players
Company websites and detailed study of their portfolio
Gold standard magazines, journals, whitepapers, press releases, and news articles
Databases

The key data points taken from the secondary sources include:

Segmentations, split-ups, and percentage shares
Data for market value
Key industry trends of the top players in the market
Qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
Quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

Autonomous surgical robotics is a cutting-edge field that combines artificial intelligence (AI), robotics, and medical technology to enable precise and automated surgical procedures. These systems have the potential to revolutionize the healthcare landscape by enhancing surgical accuracy, reducing human error, and enabling minimally invasive surgeries. The global market for autonomous surgical robotics is on a trajectory of witnessing substantial growth, driven by the increasing adoption of minimally invasive surgeries, technological advancements with respect to surgical equipment, and the need for enhanced surgical capabilities.

The healthcare system is adopting advanced technologies, especially in the field of surgical medicine, to improve surgical workflow patterns and derive quality and accurate clinical outcomes. The use of an autonomous surgical robotic system offers a safer surgical procedure by making it more accurate and minimally invasive for patients.

Some of the prominent companies in this market are:

Beijing Baihui Weikang Technology Co., Ltd.
Curexo, Inc.
Globus Medical, Inc.
Medtronic plc
PROCEPT BioRobotics Corporation
Renishaw plc
Robocath, Inc.
Stryker Corporation
Surgical Automations, Inc.
Veebot Systems, Inc.
Venus Concept Inc.
Zimmer Biomet Holdings, Inc.

Companies that are not a part of the aforementioned pool have been well represented across different sections of the report (wherever applicable).

*PDF email from publisher allows for 1-3 users, with permission to print*

Please Note: It will take 7-10 business days to complete the report upon order confirmation.